德固特(300950.SZ):取得1項實用新型專利證書 為一種相變換熱器
格隆匯12月3日丨德固特(300950.SZ)公佈,公司於近日取得中華人民共和國國家知識產權局頒發的1項實用新型專利證書,專利名稱為一種相變換熱器。
該實用新型專利涉及一種相變換熱器,尤其涉及包含液體向氣體相變過程的換熱器,包括沸騰段和過熱段兩大部分。該設備能解決在換熱過程中有相變時,尤其有液體向氣體相變的換熱過程,劇烈沸騰產生氣蝕導致設備壽命短的問題,並能獲得過熱的氣體。該技術已應用於公司部分產品中。
上述實用新型專利所涉及的技術及應用領域與公司產品相關,不會對公司生產經營產生重大影響,但有利於公司進一步完善知識產權保護體系,發揮自主知識產權優勢,促進技術創新,提高公司的綜合競爭能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.